Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C30H33FN8O2S |
| Molecular Weight | 588.699 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC1=C(N(C)C2=NC(=C(S2)C#N)C3=CC=C(F)C=C3)N4C=C(C=C(C)C4=N1)N5CCN(CC(=O)N6CC(O)C6)CC5
InChI
InChIKey=REQQVBGILUTQNN-UHFFFAOYSA-N
InChI=1S/C30H33FN8O2S/c1-4-24-29(35(3)30-34-27(25(14-32)42-30)20-5-7-21(31)8-6-20)39-15-22(13-19(2)28(39)33-24)37-11-9-36(10-12-37)18-26(41)38-16-23(40)17-38/h5-8,13,15,23,40H,4,9-12,16-18H2,1-3H3
| Molecular Formula | C30H33FN8O2S |
| Molecular Weight | 588.699 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Q13822|||Q9UCR1 Gene ID: 5168.0 Gene Symbol: ENPP2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/28414242 |
131.0 nM [IC50] |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis. | 2017-05-11 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:49:28 GMT 2025
by
admin
on
Mon Mar 31 20:49:28 GMT 2025
|
| Record UNII |
I02418V13W
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
570616
Created by
admin on Mon Mar 31 20:49:28 GMT 2025 , Edited by admin on Mon Mar 31 20:49:28 GMT 2025
|
||
|
FDA ORPHAN DRUG |
723919
Created by
admin on Mon Mar 31 20:49:28 GMT 2025 , Edited by admin on Mon Mar 31 20:49:28 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/16/1712
Created by
admin on Mon Mar 31 20:49:28 GMT 2025 , Edited by admin on Mon Mar 31 20:49:28 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
HI-130
Created by
admin on Mon Mar 31 20:49:28 GMT 2025 , Edited by admin on Mon Mar 31 20:49:28 GMT 2025
|
PRIMARY | |||
|
DB15403
Created by
admin on Mon Mar 31 20:49:28 GMT 2025 , Edited by admin on Mon Mar 31 20:49:28 GMT 2025
|
PRIMARY | |||
|
100000183725
Created by
admin on Mon Mar 31 20:49:28 GMT 2025 , Edited by admin on Mon Mar 31 20:49:28 GMT 2025
|
PRIMARY | |||
|
90420193
Created by
admin on Mon Mar 31 20:49:28 GMT 2025 , Edited by admin on Mon Mar 31 20:49:28 GMT 2025
|
PRIMARY | |||
|
I02418V13W
Created by
admin on Mon Mar 31 20:49:28 GMT 2025 , Edited by admin on Mon Mar 31 20:49:28 GMT 2025
|
PRIMARY | |||
|
C170396
Created by
admin on Mon Mar 31 20:49:28 GMT 2025 , Edited by admin on Mon Mar 31 20:49:28 GMT 2025
|
PRIMARY | |||
|
11017
Created by
admin on Mon Mar 31 20:49:28 GMT 2025 , Edited by admin on Mon Mar 31 20:49:28 GMT 2025
|
PRIMARY | |||
|
1628260-79-6
Created by
admin on Mon Mar 31 20:49:28 GMT 2025 , Edited by admin on Mon Mar 31 20:49:28 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |